Rawia M. Khalil

946 total citations
34 papers, 757 citations indexed

About

Rawia M. Khalil is a scholar working on Pharmaceutical Science, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rawia M. Khalil has authored 34 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rawia M. Khalil's work include Advancements in Transdermal Drug Delivery (14 papers), Advanced Drug Delivery Systems (12 papers) and Drug Solubulity and Delivery Systems (9 papers). Rawia M. Khalil is often cited by papers focused on Advancements in Transdermal Drug Delivery (14 papers), Advanced Drug Delivery Systems (12 papers) and Drug Solubulity and Delivery Systems (9 papers). Rawia M. Khalil collaborates with scholars based in Egypt. Rawia M. Khalil's co-authors include Mona Basha, Mohamed A. Kassem, M. Ghorab, Ali Abdel‐Rahman, Marwa F. Ahmed, Ahmed Abdelbary, Mamdouh Ghorab, Ghada E. A. Awad, Silvia Kocova El-Arini and Ghada A. Abdelbary and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Rawia M. Khalil

33 papers receiving 728 citations

Peers

Countries citing papers authored by Rawia M. Khalil

Since Specialization

Citations

This map shows the geographic impact of Rawia M. Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rawia M. Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rawia M. Khalil more than expected).

Fields of papers citing papers by Rawia M. Khalil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rawia M. Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rawia M. Khalil. The network helps show where Rawia M. Khalil may publish in the future.

Co-authorship network of co-authors of Rawia M. Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Rawia M. Khalil. A scholar is included among the top collaborators of Rawia M. Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rawia M. Khalil. Rawia M. Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel surfactant-based elastic vesicular system as a promising approach for the topical delivery of Ibuprofen for enhanced wound healing 2025 ·Journal of Pharmaceutical Sciences ·Rawia M. Khalil, (unknown), Mohamed F. Abdelhameed, Marwa E. Shabana, (unknown)	0
2	Design and Evaluation of Carvedilol Ethosomes using Box-Behnken Design 2024 ·Asmaa M. Elbakry, (unknown), Rawia M. Khalil, (unknown), (unknown)	1
3	Enhancement of the Anti-inflammatory Efficacy of Betamethasone Valerate via Niosomal Encapsulation 2021 ·Biointerface Research in Applied Chemistry ·Magdy I. Mohamed, (unknown), Rawia M. Khalil, (unknown), (unknown), Abeer Salama, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	12
4	Development of Lecithin/Chitosan Nanoparticles for Promoting Topical Delivery of Propranolol Hydrochloride: Design, Optimization and In-Vivo Evaluation 2020 ·Journal of Pharmaceutical Sciences ·Rawia M. Khalil, Silvia Kocova El-Arini, Mona M. AbouSamra, (unknown), (unknown), Ahmed Abd El-Bary	18
5	Bioanalytical Comparison of Transdermal Delivery of Tizanidine from Different Nanovesicular Carriers 2020 ·Journal of Pharmaceutical Innovation ·Faten Farouk, Rawia M. Khalil, Ahmed Abdelbary, Silvia Kocova El-Arini, Mona Basha, (unknown)	4
6	Development of tizanidine loaded aspasomes as transdermal delivery system: ex-vivo and in-vivo evaluation 2019 ·Journal of Liposome Research ·Rawia M. Khalil, Ahmed Abdelbary, Silvia Kocova El-Arini, Mona Basha, (unknown), Faten Farouk	27
7	EFFECT OF ZNCONCENTRATION IONS ON CORROSION BEHAVIOR OF ZINC PHOSPHATE CONVERSION COATING ON AL-MG-ZN ALLOY 2019 ·Journal of Al-Azhar University Engineering Sector ·(unknown), M.M. Sadawy, Rawia M. Khalil	3
8	Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: In-vitro optimization and in-vivo performance in humans 2014 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Ahmed A. Aboelwafa, Rawia M. Khalil, Omaima N. El‐Gazayerly	18
9	Baclofen novel gastroretentive extended release gellan gum superporous hydrogel hybrid system: in vitro and in vivo evaluation 2014 ·Drug Delivery ·(unknown), Ahmed A. Aboelwafa, Rawia M. Khalil, Omaima N. El‐Gazayerly	23
10	Characterization of ternary solid dispersions of nimesulide with Inutec SP1 and β-cyclodextrin and evaluation of anti-inflammatory efficiency in rats 2013 ·Egyptian Pharmaceutical Journal ·Rawia M. Khalil, Mamdouh Ghorab, (unknown), Silvia Kocova El-Arini	1
11	Influence of formulation parameters on the physicochemical properties of meloxicam-loaded solid lipid nanoparticles 2013 ·Egyptian Pharmaceutical Journal ·Rawia M. Khalil, Ahmed Abd El-Bary, (unknown), Mamdouh Ghorab, Mona Basha	13
12	Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam 2013 ·Pharmaceutical Development and Technology ·Rawia M. Khalil, Ahmed Abdelbary, (unknown), Mamdouh Ghorab, Mona Basha	64
13	SOLID LIPID NANOPARTICLES FOR TOPICAL DELIVERY OF MELOXICAM: DEVELOPMENT AND IN VITRO CHARACTERIZATION 2013 ·European Scientific Journal ESJ ·Rawia M. Khalil, Ahmed Abd El-Bary, (unknown), Mamdouh Ghorab, (unknown)	27
14	Niosomal encapsulation of the antitubercular drug, pyrazinamide 2011 ·Drug Development and Industrial Pharmacy ·(unknown), Ahmed Abdelbary, (unknown), Rawia M. Khalil, Dina Mostafa, Ahmed I. El‐Batal, Sameh Hosam Abd El-Alim	37
15	Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes. 2008 ·PubMed ·Ahmed Abd El-Bary, (unknown), (unknown), Rawia M. Khalil	21
16	Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs 2007 ·International Journal of Pharmaceutics ·Mohamed A. Kassem, Ali Abdel‐Rahman, M. Ghorab, Marwa F. Ahmed, Rawia M. Khalil	216
17	Corrosion inhibition of aluminium by some picrate salts 2004 ·Rawia M. Khalil, (unknown)	1
18	Free versus liposome-encapsulated lignocaine hydrochloride topical applications. 1999 ·PubMed ·(unknown), Rawia M. Khalil	9
19	Cyclodextrins in acetazolamide eye drop formulations. 1998 ·PubMed ·Hussein O. Ammar, (unknown), Rawia M. Khalil	4
20	Effect of urea on the activity of certain ophthalmic drugs in man. 1983 ·PubMed ·(unknown), Salama Ha, Rawia M. Khalil, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact